These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 2084321)
1. [Autoantibodies against the complement component C1q in systemic lupus erythematosus]. Antes U; Heinz HP; Hartung K; Loos M Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321 [TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Antes U; Heinz HP; Loos M Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749 [TBL] [Abstract][Full Text] [Related]
3. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. Uwatoko S; Mannik M J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124 [TBL] [Abstract][Full Text] [Related]
4. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities. Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245 [TBL] [Abstract][Full Text] [Related]
5. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404 [TBL] [Abstract][Full Text] [Related]
6. Autoreactivity to mouse C1q in a murine model of SLE. Trinder PK; Maeurer MJ; Schorlemmer HU; Loos M Rheumatol Int; 1995; 15(3):117-20. PubMed ID: 8588121 [TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989 [TBL] [Abstract][Full Text] [Related]
8. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against C1q in patients with systemic lupus erythematosus. Trendelenburg M Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648 [TBL] [Abstract][Full Text] [Related]
10. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways. Thanei S; Vanhecke D; Trendelenburg M Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903 [TBL] [Abstract][Full Text] [Related]
11. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. Wisnieski JJ; Jones SM J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123 [TBL] [Abstract][Full Text] [Related]
12. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system. Antes U; Heinz HP; Loos M J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573 [TBL] [Abstract][Full Text] [Related]
14. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471 [TBL] [Abstract][Full Text] [Related]
16. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia. Agnello V; Mitamura T Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis. Cook AD; Rowley MJ; Wines BD; Mackay IR J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456 [TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]